Development of Avian Avulavirus 1 Epitope-Based Vaccine Pattern Based on Epitope Prediction and Molecular Docking Analysis: An Immunoinformatic Approach
- 12 Downloads
Fusion (F) and Hemagglutinin-neuraminidase (HN) glycoproteins of Newcastle disease virus containing important epitopes play crucial role in stimulation of humoral and cell-mediated immunity of the host. In the present study we analyzed and compared genetic diversity of F and HN sequences related to long-term circulating sub-genotype VIIj isolates to genotype VII and II strains. In addition, F and HN epitope prediction was performed using IEDB, NetMHC 4.0 and NetMHC II 3.1 servers. Molecular docking analysis was also conducted for VIIj and LaSota isolates interacting MHC I and II molecules. Results indicated that certain specific mutations were occurred in Fusion and Hemagglutinin-neuraminidase proteins of VIIj sub-genotype. Epitope prediction study revealed that the unique variations were located on the antigenic site regions of F and HN glycoproteins. Furthermore, docking interaction analysis showed surprising results, in which defined antigenic site residues of VIIj isolates interacted to MHC molecules with higher affinity levels rather than LaSota strains used as vaccines. Our in silico results suggest that by applying certain epitope sequences inducing both immune responses, vaccination failures may be reduced and challenged vaccinated host cells may stop viral shedding beside protection from Newcastle disease infection. Thus, we recommend the introduced antigenic sites of VIIj sub-genotype in this paper would act as the great targets for epitope-based vaccine design in the region.
KeywordsImmunoinformatics Fusion Hemagglutinin-neuraminidase Epitope-based vaccine Avian Avulavirus 1 Molecular docking
This study was supported by Grant No. 2-18-18-94129 Razi Vaccine and Serum Research Institute.
Compliance with Ethical Standards
Conflict of interest
The authors declare no competing interests.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Alexander DJ (1997) Newcastle disease and other avian Paramyxoviridae infection. In: Calnek BW, Barnes HJ, Beard CW, McDougald LR, Saif YM (eds) Diseases of Poultry. Iowa State University Press, Ames, pp 541–549Google Scholar
- Amarasinghe GK, Bào Y, Basler CF, Bavari S, Beer M, Bejerman N, Blasdell KR, Bochnowski A, Briese T, Bukreyev A, Calisher CH, Chandran K, Collins PL, Dietzgen RG, Dolnik O, Dürrwald R, Dye JM, Easton AJ, Ebihara H, Fang Q, Formenty P, Fouchier RAM, Ghedin E, Harding RM, Hewson R, Higgins CM, Hong J, Horie M, James AP, Jiāng D, Kobinger GP, Kondo H, Kurath G, Lamb RA, Lee B, Leroy EM, Li M, Maisner A, Mühlberger E, Netesov SV, Nowotny N, Patterson JL, Payne SL, Paweska JT, Pearson MN, Randall RE, Revill PA, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Smither SJ, Song Q, Stone DM, Takada A, Terregino C, Tesh RB, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Volchkov VE, Wahl-Jensen V, Walker PJ, Wang B, Wang D, Wang F, Wang LF, Werren JH, Whitfield AE, Yan Z, Ye G, Kuhn JH (2017) Taxonomy of the order Mononegavirales: update 2017. Arch Virol 162:2493–2504. https://doi.org/10.1007/s00705-017-3311-7 CrossRefPubMedPubMedCentralGoogle Scholar
- Badawi MM, Fadl Alla AAE, Alam SS, Mohamed WA, Osman DAN, Alrazig Ali SAA, Ahmed EME, Adam AAE, Abdullah RO, Salih MA (2016) Immunoinformatics predication and in silico modeling of epitope-based peptide vaccine against virulent newcastle disease viruses. Am J Infec Dis and Microbiol 4:61–71. https://doi.org/10.12691/ajidm-4-3-3 CrossRefGoogle Scholar
- Diel DG, da Silva LHA, Liu H, Wang Z, Miller PJ, Afonso CL (2012) Genetic diversity of avian paramyxovirus type 1: proposal for a unified nomenclature and classification system of Newcastle disease virus genotypes. Infect Genet Evol 12:1770–1779. https://doi.org/10.1016/j.meegid.2012.07.012 CrossRefPubMedGoogle Scholar
- Ghalyanchilangeroudi A, Hosseini H, Jabbarifakhr M, Fallah Mehrabadi MH, Najafi H, Ghafouri SA, Mousavi FS, Ziafati Z, Modiri A (2018) Emergence of a virulent genotype VIIi of Newcastle disease virus in Iran. Avian Pathol 47:509–519. https://doi.org/10.1080/03079457.2018.1495313 CrossRefPubMedGoogle Scholar
- Li T, Wang G, Shi B, Liu P, Si W, Wang B, Jiang L, Zhou L, Xiu J, Liu H (2015) Comprehensive analysis and characterization of linear antigenic domains on HN protein from genotype vii newcastle disease virus using yeast surface display system. PLoS ONE 10:e0131723. https://doi.org/10.1371/journal.pone.0131723 CrossRefPubMedPubMedCentralGoogle Scholar
- Maminiaina OF, Gil P, Briand FX, Albina E, Keita D, Rasamoelina Andriamanivo H, Chevalier V, Lancelot R, Martinez D, Rakotondravao R, Rajaonarison JJ, Koko M, Andriantsimahavandy AA, Jestin V, Servan de Almeida R (2010) newcastle disease virus in madagascar: identification of an original genotype possibly deriving from a died out ancestor of genotype IV. PLoS ONE 5:e13987. https://doi.org/10.1371/journal.pone.0013987 CrossRefPubMedPubMedCentralGoogle Scholar
- Miller PJ, King DJ, Afonso CL, Suarez DL (2007) Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25:7238–7246. https://doi.org/10.1016/j.vaccine.2007.07.017 CrossRefPubMedGoogle Scholar
- Munir M, Linde AM, Zohari S, Stahl K, Baule C, Engstrom B, Renstrom LHM, Berg M (2011) Whole genome sequencing and characterization of a virulent Newcastle disease virus isolated from an outbreak in Sweden. Virus Genes 43:261–271. https://doi.org/10.1007/s11262-011-0636-2 CrossRefPubMedGoogle Scholar
- OIE (World Organisation for Animal Health) (2012) Newcastle disease (infection with Newcastle disease virus). www.oie.int/fileadmin/Home/eng/Health_standards/tahc/current/chapitre_nd.pdf. Accessed 2012
- Osman MM, ElAmin EE, Al-Nour MY, Alam SS, Adam RS, Ahmed AA, Elsayed AA, Abdalla MH, Salih MA (2016) In silico design of epitope based peptide vaccine against virulent strains of (HN)-Newcastle disease virus (NDV) in poultry Species. Int J of Multidiscip Curr Res 4:868–878Google Scholar
- Shahriari AG, Bagheri A, Bassami MR, Malekzadeh-Shafaroudia S, Afsharifar A, Niazi A (2016) Expression of Hemagglutinin-Neuraminidase and fusion epitopes of Newcastle disease virus in transgenic tobacco. Electron J Biotechnol 22:38–43. https://doi.org/10.1016/j.ejbt.2016.05.003 CrossRefGoogle Scholar
- Shi J, Zhang J, Li S, Sun J, Teng Y, Wu M, Li J, Li Y, Hu N, Wang H, Hu Y (2015) Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in silico approach applied to emerging infectious diseases. PLoS ONE 10:e0144475. https://doi.org/10.1371/journal.pone.0144475 CrossRefPubMedPubMedCentralGoogle Scholar
- Yusoff K, Nesbit M, McCartney H, Meulemans G, Alexander DJ, Collins MS, Emmerson PT, Samsoni ACR (1989) Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol 70:3105–3109. https://doi.org/10.1099/0022-1317-70-11-3105 CrossRefPubMedGoogle Scholar